Stocksigma LogoStocksigma Logo

CARE Ratings Issues Q2FY27 Monitoring Agency Report for Stallion India Fluorochemicals

CARE Ratings reported that out of Stallion India Fluorochemicals’ ₹160.73 crore IPO proceeds, ₹160.33 crore was utilized through 30th Sep'26, leaving ₹0.40

CARE Ratings Issues Q2FY27 Monitoring Agency Report for Stallion India Fluorochemicals

Stallion India Fluorochemicals Ltd · Others (Uncategorized) · 14 Nov 2026, 10:33 pm

CARE Ratings Issues Q2FY27 Monitoring Agency Report for Stallion India Fluorochemicals CARE Ratings reported that out of Stallion India Fluorochemicals’ ₹160.73 crore IPO proceeds, ₹160.33 crore was utilized through 30th Sep'26, leaving ₹0.40 crore parked in an ICICI Bank fixed deposit maturing 10th Mar'27. A minor deviation of ₹0.40 crore occurred as the company counted internal funds toward IPO objects. Furthermore, capex at the Mambattu facility experienced delays and cost overruns due to capacity doubling, now targeted for completion by Jan'27 funded via internal accruals. Capex at the Khalapur plant concluded with a 334-day delay.

Original exchange filing (PDF)

More announcements from Stallion India Fluorochemicals Ltd

All Stallion India Fluorochemicals Ltd announcements